Quantative Computing (Qubidism) technology, which uses qubits that can be zero and one simultaneously, is challenging to both finance and value. Unlike biotech startups that are raising money for scientific breakthroughs, these companies tend to be more successful in the public market. However, private investments are essential in these deals. Shareholders can redeem their investment in cash prior to a merger's completion, with redemption rates reaching 95%. More than 30 countries have launched national quantum strategies for quantum computing, with stakes being highest for the EU, Canada, and the UK.